Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy
暂无分享，去创建一个
[1] R. Hunt,et al. Acid suppression in healthy subjects following lansoprazole or pantoprazole , 2002, Alimentary pharmacology & therapeutics.
[2] R. Hunt,et al. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion. , 1997, Clinical therapeutics.
[3] M. Hongo,et al. Effect of lansoprazole on intragastric pH , 1992, Digestive Diseases and Sciences.
[4] L. Witzel,et al. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers. , 1988, Gut.
[5] R. Hunt,et al. Relationship between gastric secretion and infection. , 1987, Gut.
[6] C. Fimmel,et al. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. , 1985, Gastroenterology.
[7] C. Wilder-Smith,et al. Esomeprazole 20mg Provides More Effective Intragastric Acid Control than Maintenance-Dose Rabeprazole, Lansoprazole or Pantoprazole in Healthy Volunteers , 2004, Clinical drug investigation.
[8] G. Cook. Infective gastroenteritis and its relationship to reduced gastric acidity. , 1985, Scandinavian journal of gastroenterology. Supplement.
[9] A. Thomson,et al. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease. , 1984, Clinical therapeutics.